Katie Hill, MPH
she/her/hers
DownloadHi-Res Photo
Cards
Contact Info
Education
MPH
Milken Institute School of Public Health at George Washington University, Epidemiology (2022)
Milken Institute School of Public Health at George Washington University, Epidemiology (2022)
BA
University of Virginia, Biology and Interdisciplinary Studies (2018)
University of Virginia, Biology and Interdisciplinary Studies (2018)
About
Copy Link
Biography
Katherine (Katie) Hill is a PhD candidate in Epidemiology of Microbial Diseases working under the mentorship of Dr. Robert Heimer. She is also a Public Health Workforce Development Fellow with the Office of Public Health Practice. Her research interests include substance use, harm reduction, xylazine, kratom, sexual health and behavior, and improving the health of incarcerated individuals.
Last Updated on October 06, 2024.
Education & Training
- MPH
- Milken Institute School of Public Health at George Washington University, Epidemiology (2022)
- BA
- University of Virginia, Biology and Interdisciplinary Studies (2018)
Research
Copy Link
Overview
Medical Research Interests
Community-Based Participatory Research; Controlled Substances; Public Health Systems Research; Soft Tissue Injuries; Substance-Related Disorders; Veterinary Drugs
Public Health Interests
Community Health; Health Equity, Disparities, Social Determinants and Justice; Implementation Science; Mental Health; Sexually-Transmitted Infections; Stigma and Discrimination; Substance Use, Addiction
ORCID
0000-0002-6515-8701
Research at a Glance
Yale Co-Authors
Frequent collaborators of Katie Hill's published research.
Jenna L. Butner, MD, MPH, FASAM, AAHIVS
Robert Heimer, PhD
Benjamin Howell, MD, MPH, MHS
Emma Biegacki, MPH
Lauretta Grau, PhD
Mahalia S. Desruisseaux, MD
Publications
2025
De facto opioids: Characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing.
Hill K, Boyer EW, Grundmann O, Smith KE. De facto opioids: Characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing. Drug Alcohol Depend 2025, 272: 112701. PMID: 40373645, DOI: 10.1016/j.drugalcdep.2025.112701.Peer-Reviewed Original ResearchAt least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use.
Hill K, Rogers JM, Grundmann O, Epstein DH, Smith KE. At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use. Am J Drug Alcohol Abuse 2025, 51: 191-203. PMID: 39883932, DOI: 10.1080/00952990.2024.2414319.Peer-Reviewed Original Research
2024
In Support of the Decriminalization of Personal Drug and Paraphernalia Use and Possession: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use and Addiction)
Hill K, Dunham K, Doneski K, Sue K, Thakarar K, Butner J. In Support of the Decriminalization of Personal Drug and Paraphernalia Use and Possession: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use and Addiction). Substance Abuse 2024, 46: 4-12. PMID: 39215532, DOI: 10.1177/29767342241277619.Peer-Reviewed Original ResearchCitationsAltmetricConceptsDrug offensesDrug useCriminalization of drug useSocial safety netDecriminalization of drugsHarm reduction servicesWell-beingHarm reduction strategiesConsequences of drug useWell-being of peopleNegative consequences of drug useCommunity supervisionAddiction treatment servicesHealth of PWUDCriminal sanctionsSafety netReduction servicesTreatment servicesDecriminalizationAddiction servicesIllicit drugsOffensesNegative consequencesPWUDUnited StatesProviders’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study
Hill K, Minahan-Rowley R, Biegacki E, Heimer R, Sue K. Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study. Harm Reduction Journal 2024, 21: 148. PMID: 39148036, PMCID: PMC11328386, DOI: 10.1186/s12954-024-01052-4.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsSequential explanatory mixed-methods studyExplanatory mixed-methods studyMixed-methods studyHealthcare providersHealthcare providers' experiencesHealthcare providers treating patientsSample of providersProviders treating patientsDrug supplyProvider experienceProvider knowledgeIn-depth interviewsImprove careSense of helplessnessConvenience sampleHealthcare educationThematic analysisInterview transcriptsQualitative phasePurposive samplingProvidersHealthcareOpioid supplyAbsence of literatureResultsSeventy-eightPostrelease Risk of Overdose and All-Cause Death Among Persons Released From Jail or Prison: Minnesota, March 2020-December 2021.
Hill K, Bodurtha P, Winkelman T, Howell B. Postrelease Risk of Overdose and All-Cause Death Among Persons Released From Jail or Prison: Minnesota, March 2020-December 2021. American Journal Of Public Health 2024, 114: 913-922. PMID: 39024534, PMCID: PMC11306622, DOI: 10.2105/ajph.2024.307723.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsOverdose deathsPrison exposureJailPrisonRisk of overdoseRates of overdose deathsOverdose death ratesOpioid use disorderGeneral populationDeath recordsDrug overdosePeopleStandardized mortality ratioPersonsIncarcerationUse disorderPostreleaseMortality ratioDeath rateRisk of deathRetrospective cohort studyMortality riskCohort studyMinnesotaOverdoseUse of Cannabinoids by People Who Consume Kratom in the United States.
Hill K, Grundmann O, Panlilio LV, Epstein DH, Smith KE. Use of Cannabinoids by People Who Consume Kratom in the United States. J Addict Med 2024 PMID: 39012004, DOI: 10.1097/ADM.0000000000001346.Peer-Reviewed Original ResearchKratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency.
Rogers JM, Weiss ST, Epstein DH, Grundmann O, Hill K, Smith KE. Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency. Drug Alcohol Depend 2024, 260: 111329. PMID: 38788532, DOI: 10.1016/j.drugalcdep.2024.111329.Peer-Reviewed Original ResearchIn Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)
Dunham K, Hill K, Kazal H, Butner J, Hull I, Sue K, Li L, Doneski K, Dinges B, Rife-Pennington T, Kung S, Thakarar K. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction). Substance Abuse 2024, 45: 328-336. PMID: 38747578, DOI: 10.1177/29767342241252590.Peer-Reviewed Original ResearchCitationsAltmetricConceptsPrevention CenterRates of fatal overdoseSubstance Use and AddictionDrop-in serviceEvidence-based strategiesHarm reduction strategiesMultidisciplinary Education and ResearchUnited StatesLifesaving servicesMedical careAdvocacy effortsIncrease accessPosition statementSocial servicesFatal overdoseEducation and ResearchDrug supplyTrained personnelPWUDPolicy changesFederal levelReduction strategiesInternational dataSterile suppliesServicesPrevalence of Kratom Use Disorder among Kratom Consumers.
Hill K, Grundmann O, Smith KE, Stanciu CN. Prevalence of Kratom Use Disorder among Kratom Consumers. J Addict Med 2024 PMID: 38441236, DOI: 10.1097/ADM.0000000000001290.Peer-Reviewed Original ResearchIn Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction)
Hill K, Dunham K, Brokos Z, et al. In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction). Substance Use & Addiction Journal. 2024;45(1):4-9. doi:10.1177/29767342231212787Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
News
Copy Link
News
- May 23, 2025Source: CT Mirror
CT’s health commissioners should support overdose prevention centers
- April 07, 2025Source: Hartford Courant
Opinion: The need for overdose prevention centers in Connecticut
- August 20, 2024
Cause of Death After Prison Release Differs From General Population
- March 14, 2024Source: CT Mirror
For CT’s incarcerated, health care becomes an opportunity for punishment
Get In Touch
Copy Link
Contacts
Email